Castle Biosciences Inc (CSTL) stock news · rev $344.2M
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
This CSTL news page leads with what Castle Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for CSTL yet. We will not pad this page with generic market recap.
Latest reported CSTL revenue for 2025-12-31 was $344.2M. Net income was -$24.2M. Revenue was up 3.7% from 2024-12-31 to 2025-12-31. CSTL currently screens at market cap $570.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CSTL stock page; for the tape open the quote page.
CSTL stock news FAQ
What are CSTL's latest revenue and net income?
Latest cached Castle Biosciences Inc (CSTL) revenue for Dec 31, 2025 was $344.2M. Net income was -$24.2M. Statements: https://lician.com/financials/cstl
How did CSTL revenue change from the prior cached period?
Cached Castle Biosciences Inc (CSTL) revenue was up 3.7% from $332.1M (Dec 31, 2024) to $344.2M (Dec 31, 2025). Statements: https://lician.com/financials/cstl
What is CSTL's market cap?
Castle Biosciences Inc (CSTL) market cap is $570.2M on the latest cached fundamentals snapshot.
What kind of company is CSTL?
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Where is CSTL stock news listed?
Cached stock news for Castle Biosciences Inc (CSTL) is listed at https://lician.com/news/cstl. Filings: https://lician.com/sec/cstl
Not investment advice.